RTX Corp: Form 10-Q for the period ended Sep 30, 2018
Filed with the SEC on Oct 26, 2018 and accepted by EDGAR at Oct 26, 2018, 08:51 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2018-07-01 to 2018-09-30 | $16.51bn | us-gaap:Revenues |
| Revenue | 9 months2018-01-01 to 2018-09-30 | $48.46bn | us-gaap:Revenues |
| Research and development | 3 months2018-07-01 to 2018-09-30 | $586.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2018-01-01 to 2018-09-30 | $1.73bn | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2018-07-01 to 2018-09-30 | $1.68bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2018-01-01 to 2018-09-30 | $5.15bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2018-07-01 to 2018-09-30 | $1.84bn | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2018-01-01 to 2018-09-30 | $6.64bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2018-07-01 to 2018-09-30 | $258.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2018-01-01 to 2018-09-30 | $721.0m | us-gaap:InterestExpense |
| Income tax | 3 months2018-07-01 to 2018-09-30 | $419.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2018-01-01 to 2018-09-30 | $1.64bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2018-07-01 to 2018-09-30 | $1.24bn | us-gaap:NetIncomeLoss |
| Net income | 9 months2018-01-01 to 2018-09-30 | $4.58bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2018-07-01 to 2018-09-30 | $1.54 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2018-01-01 to 2018-09-30 | $5.72 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2018-07-01 to 2018-09-30 | $1.56 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2018-01-01 to 2018-09-30 | $5.80 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2018-07-01 to 2018-09-30 | 801,800,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2018-01-01 to 2018-09-30 | 800,700,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2018-01-01 to 2018-09-30 | $4.32bn | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 9 months2018-01-01 to 2018-09-30 | $1.12bn | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 9 months2018-01-01 to 2018-09-30 | $1.61bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2018-01-01 to 2018-09-30 | $72.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2018-09-30 | $13.80bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2018-09-30 | $40.20bn | us-gaap:AssetsCurrent |
| Total assets | At period end2018-09-30 | $114.94bn | us-gaap:Assets |
| Current liabilities | At period end2018-09-30 | $26.50bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2018-09-30 | $80.56bn | us-gaap:Liabilities |
| Short-term borrowings | At period end2018-09-30 | $1.58bn | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2018-09-30 | $32.11bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2018-09-30 | 800,984,201 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000101829-18-000043. Last ingested by Listed: Nov 3, 2026, 21:25 ET. Listed shows no prices and gives no investment advice.